Glaxo To Invest USD100 Million In US Vaccine Manufacturing Site
LONDON (Alliance News) - GlaxoSmithKline PLC said on Wednesday it will invest USD100 million in its manufacturing site in Montana, US, to expand long-term vaccine manufacturing particular, the 100 Read More